Moore S - Search Results

1

Effect of curcumin-associated and lipid ligand-functionalized nanoliposomes on aggregation of the Alzheimer's Aβ peptide.

Taylor M, Moore S, Mourtas S, Niarakis A, Re F, Zona C, La Ferla B, Nicotra F, Masserini M, Antimisiaris SG, Gregori M, Allsop D. Taylor M, et al. Among authors: moore s. Nanomedicine. 2011 Oct;7(5):541-50. doi: 10.1016/j.nano.2011.06.015. Epub 2011 Jun 29. Nanomedicine. 2011. PMID: 21722618

2

Development of a proteolytically stable retro-inverso peptide inhibitor of beta-amyloid oligomerization as a potential novel treatment for Alzheimer's disease.

Taylor M, Moore S, Mayes J, Parkin E, Beeg M, Canovi M, Gobbi M, Mann DM, Allsop D. Taylor M, et al. Among authors: moore s. Biochemistry. 2010 Apr 20;49(15):3261-72. doi: 10.1021/bi100144m. Biochemistry. 2010. PMID: 20230062

3

Fluorescence anisotropy: a method for early detection of Alzheimer beta-peptide (Abeta) aggregation.

Allsop D, Swanson L, Moore S, Davies Y, York A, El-Agnaf OM, Soutar I. Allsop D, et al. Among authors: moore s. Biochem Biophys Res Commun. 2001 Jul 6;285(1):58-63. doi: 10.1006/bbrc.2001.5123. Biochem Biophys Res Commun. 2001. PMID: 11437372

4

Both the D-(+) and L-(-) enantiomers of nicotine inhibit Abeta aggregation and cytotoxicity.

Moore SA, Huckerby TN, Gibson GL, Fullwood NJ, Turnbull S, Tabner BJ, El-Agnaf OM, Allsop D. Moore SA, et al. Biochemistry. 2004 Jan 27;43(3):819-26. doi: 10.1021/bi035728h. Biochemistry. 2004. PMID: 14730987

5

Metal-dependent generation of reactive oxygen species from amyloid proteins implicated in neurodegenerative disease.

Allsop D, Mayes J, Moore S, Masad A, Tabner BJ. Allsop D, et al. Among authors: moore s. Biochem Soc Trans. 2008 Dec;36(Pt 6):1293-8. doi: 10.1042/BST0361293. Biochem Soc Trans. 2008. PMID: 19021543 Review.

6

3-p-Toluoyl-2-[4'-(3-diethylaminopropoxy)-phenyl]-benzofuran and 2-[4'-(3-diethylaminopropoxy)-phenyl]-benzofuran do not act as surfactants or micelles when inhibiting the aggregation of beta-amyloid peptide.

Allsop D, Gibson G, Martin IK, Moore S, Turnbull S, Twyman LJ. Allsop D, et al. Among authors: moore s. Bioorg Med Chem Lett. 2001 Jan 22;11(2):255-7. doi: 10.1016/s0960-894x(00)00645-4. Bioorg Med Chem Lett. 2001. PMID: 11206472

7

Galantamine inhibits beta-amyloid aggregation and cytotoxicity.

Matharu B, Gibson G, Parsons R, Huckerby TN, Moore SA, Cooper LJ, Millichamp R, Allsop D, Austen B. Matharu B, et al. J Neurol Sci. 2009 May 15;280(1-2):49-58. doi: 10.1016/j.jns.2009.01.024. Epub 2009 Feb 26. J Neurol Sci. 2009. PMID: 19249060

8

Modulation of beta-amyloid production and fibrillization.

Allsop D, Twyman LJ, Davies Y, Moore S, York A, Swanson L, Soutar I. Allsop D, et al. Among authors: moore s. Biochem Soc Symp. 2001;(67):1-14. doi: 10.1042/bss0670001. Biochem Soc Symp. 2001. PMID: 11447825 Review.

9

alpha-Synuclein implicated in Parkinson's disease catalyses the formation of hydrogen peroxide in vitro.

Turnbull S, Tabner BJ, El-Agnaf OM, Moore S, Davies Y, Allsop D. Turnbull S, et al. Among authors: moore s. Free Radic Biol Med. 2001 May 15;30(10):1163-70. doi: 10.1016/s0891-5849(01)00513-5. Free Radic Biol Med. 2001. PMID: 11369507

10

Donepezil for severe Alzheimer's disease.

Allsop D, Martin FL, Moore S, Fullwood NJ; Alzheimer's Society. Allsop D, et al. Among authors: moore s. Lancet. 2006 Jul 29;368(9533):361; author reply 362. doi: 10.1016/S0140-6736(06)69097-1. Lancet. 2006. PMID: 16876652 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,024 results

Search Page

Filters